148 related articles for article (PubMed ID: 30093628)
1. Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.
Wong D; Lounsbury K; Lum A; Song J; Chan S; LeBlanc V; Chittaranjan S; Marra M; Yip S
Oncogene; 2019 Jan; 38(2):273-290. PubMed ID: 30093628
[TBL] [Abstract][Full Text] [Related]
2. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
[TBL] [Abstract][Full Text] [Related]
3. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization.
Lee Y; Fryer JD; Kang H; Crespo-Barreto J; Bowman AB; Gao Y; Kahle JJ; Hong JS; Kheradmand F; Orr HT; Finegold MJ; Zoghbi HY
Dev Cell; 2011 Oct; 21(4):746-57. PubMed ID: 22014525
[TBL] [Abstract][Full Text] [Related]
4. Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma.
Xu F; Viaene AN; Ruiz J; Schubert J; Wu J; Chen J; Cao K; Fu W; Bagatell R; Fan Z; Long A; Pagliaroli L; Zhong Y; Luo M; Kreiger PA; Surrey LF; Wertheim GB; Cole KA; Li MM; Santi M; Storm PB
Acta Neuropathol Commun; 2022 Jul; 10(1):102. PubMed ID: 35836290
[TBL] [Abstract][Full Text] [Related]
5. ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.
Wang B; Krall EB; Aguirre AJ; Kim M; Widlund HR; Doshi MB; Sicinska E; Sulahian R; Goodale A; Cowley GS; Piccioni F; Doench JG; Root DE; Hahn WC
Cell Rep; 2017 Feb; 18(6):1543-1557. PubMed ID: 28178529
[TBL] [Abstract][Full Text] [Related]
6. Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade.
LeBlanc VG; Firme M; Song J; Chan SY; Lee MH; Yip S; Chittaranjan S; Marra MA
J Pathol; 2017 Jun; 242(2):206-220. PubMed ID: 28295365
[TBL] [Abstract][Full Text] [Related]
7. Making heads or tails - the emergence of capicua (CIC) as an important multifunctional tumour suppressor.
Wong D; Yip S
J Pathol; 2020 Apr; 250(5):532-540. PubMed ID: 32073140
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.
Kim E; Lu HC; Zoghbi HY; Song JJ
Genes Dev; 2013 Mar; 27(6):590-5. PubMed ID: 23512657
[TBL] [Abstract][Full Text] [Related]
9. Structural Analysis and Spatiotemporal Expression of
Vauti F; Vögele V; Deppe I; Hahnenstein ST; Köster RW
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768779
[TBL] [Abstract][Full Text] [Related]
10. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
[TBL] [Abstract][Full Text] [Related]
11. The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.
Weissmann S; Cloos PA; Sidoli S; Jensen ON; Pollard S; Helin K
Cancer Res; 2018 Aug; 78(15):4114-4125. PubMed ID: 29844126
[TBL] [Abstract][Full Text] [Related]
12. Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia.
Siegfried A; Masliah-Planchon J; Roux FE; Larrieu-Ciron D; Pierron G; Nicaise Y; Gambart M; Catalaa I; Péricart S; Dubucs C; Mohand-Oumoussa B; Tirode F; Bourdeaut F; Uro-Coste E
Acta Neuropathol Commun; 2019 Dec; 7(1):220. PubMed ID: 31888756
[No Abstract] [Full Text] [Related]
13. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
14. miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.
Choi N; Park J; Lee JS; Yoe J; Park GY; Kim E; Jeon H; Cho YM; Roh TY; Lee Y
Oncotarget; 2015 Sep; 6(27):23533-47. PubMed ID: 26124181
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans.
Lu HC; Tan Q; Rousseaux MW; Wang W; Kim JY; Richman R; Wan YW; Yeh SY; Patel JM; Liu X; Lin T; Lee Y; Fryer JD; Han J; Chahrour M; Finnell RH; Lei Y; Zurita-Jimenez ME; Ahimaz P; Anyane-Yeboa K; Van Maldergem L; Lehalle D; Jean-Marcais N; Mosca-Boidron AL; Thevenon J; Cousin MA; Bro DE; Lanpher BC; Klee EW; Alexander N; Bainbridge MN; Orr HT; Sillitoe RV; Ljungberg MC; Liu Z; Schaaf CP; Zoghbi HY
Nat Genet; 2017 Apr; 49(4):527-536. PubMed ID: 28288114
[TBL] [Abstract][Full Text] [Related]
16. Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.
Didonna A; Canto Puig E; Ma Q; Matsunaga A; Ho B; Caillier SJ; Shams H; Lee N; Hauser SL; Tan Q; Zamvil SS; Oksenberg JR
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23742-23750. PubMed ID: 32878998
[TBL] [Abstract][Full Text] [Related]
17. Chemical shift assignment of the ataxin-1 AXH domain in complex with a CIC ligand peptide.
de Chiara C; Kelly G; Menon RP; McCormick J; Pastore A
Biomol NMR Assign; 2014 Oct; 8(2):325-7. PubMed ID: 23853075
[TBL] [Abstract][Full Text] [Related]
18. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.
Darabi S; Xiu J; Samec T; Kesari S; Carrillo J; Aulakh S; Walsh KM; Sengupta S; Sumrall A; Spetzler D; Glantz M; Demeure MJ
Med Oncol; 2023 Jun; 40(7):197. PubMed ID: 37291277
[TBL] [Abstract][Full Text] [Related]
19. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
[TBL] [Abstract][Full Text] [Related]
20. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
